- Endothelial Function in Aortic Syndromes
- Adult Congenital Heart Disease
- Cardiovascular Aspects of Marfan syndrome
Board Certification and Academic Information
||Pediatrics - Professor
||American Board of Pediatrics (Pediatrics)
American Board of Pediatrics (Sub: Ped Cardiology)
Royal College of Physicians and Surgeons of Canada
Royal College of Physicians and Surgeons of Canada (Peds)
Academic Office Locations
|Academic Office Phone Number
||Academic Office Address
||Primary Children's Hospital
100 N Mario Capecchi Drive
Salt Lake City, UT 84113
Dr. Yetman's career as a clinician, researcher and educator began in 1997 at the University of Arkansas for Medical Sciences, where, within five years, she rose from Assistant to Associate Professor of Pediatrics, a position she held until 2002. In 2002, Dr. Yetman assumed the role of Director of Adult Congenital Heart Disease at the University of Colorado Health Sciences Center in Denver CO. In 2006, Dr. Yetman was recruited to Primary Children’s Medical Center and the University of Utah to direct the Adult Congenital Cardiology Cardiac Program.
Dr. Yetman is currently Professor of Pediatrics with an adjunct appointment in Medicine. She continues to serve as director of the Marfan Cardiology Program in both Denver and Salt Lake City with clinics in both CO and UT. As the regional expert in Marfan syndrome and other diseases of the aorta she sees children and adults of all ages referred from various locations across the country. Her clinical practice is devoted to the care of adolescents and adults with congenital heart defects and patients of all ages with Turner syndrome, Marfan syndrome and familial aortic disease.
In 2008-2011, Dr. Yetman was awarded the National Patient’s Choice Award, an honor bestowed on few physicians nationwide who have received near perfect scores as voted on by their patients.
Dr. Yetman’s research is focused on 3 areas: i) the understanding of the mechanisms of aortic dilation and dissection, (ii) lifestyle factors influencing outcome in patients with congenital heart disease, and (iii) the impact of pregnancy on cardiac and vascular function in patients with congenital heart disease or aortic disease. Dr. Yetman is the principal investigator at the University of Utah for the NHLBI trial of Losartan vs. Atenolol in patients with Marfan syndrome. Dr. Yetman and her research team were the lead enrollers into this international trial.
Dr. Yetman has written more than 100 publications, scientific papers, chapters, and abstracts. She serves as a member of the Medical Advisory Board of the American Congenital Heart Association and is an internationally known invited speaker on the topics of Aortic Disease, and Adult Congenital Heart Disease.